What changed in this filing

/stocks — the workspaceLOADING

Item 1A. Risk Factors

2025-08-13 compared with 2025-05-13 · 54 added, 66 removed, 3 unchanged (98% of the section changed)

Investing in our common stock involves a high

degree of risk.

Before you invest you should carefully review our Management’s Discussion and Analysis of Financial Condition and

Results of Operations set forth in Item 2 of Part I of this Quarterly Report on Form 10-Q, our consolidated financial statements and related

notes included in Item 1 of Part I of this Quarterly Report on Form 10-Q and our consolidated financial statements and related notes,

as well as our Management’s Discussion and Analysis of Financial Condition and Results of Operations and the other information in

our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

Readers should carefully review risks described in other documents

we file from time to time with the Securities and Exchange Commission.

We are currently

not in compliance with the Nasdaq continued listing requirements.

If we are unable to regain compliance with Nasdaq’s listing requirements,

our securities could be delisted, which could affect our common stock’s market price and liquidity and reduce our ability to raise

May 6, 2025, the Company was notified by the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”)

that the Staff granted the Company’s request to transfer the listing of its common stock, par value $0.0005 per share (the “Common

Shares”), from The Nasdaq Global Select Market tier to The Nasdaq Capital Market tier, and that the Staff granted the Company’s

request for a second 180-calendar day period, or until November 3, 2025 (the “Second Compliance Period”), to regain compliance

with the $1.00 bid price requirement, as set forth in Nasdaq Listing Rule 5550(a)(2).

To regain compliance with such minimum price requirement,

the Company must evidence a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days.

of the listing of the Common Shares from The Nasdaq Global Select Market to The Nasdaq Capital Market took effect with the open of business

on May 8, 2025.

The transfer is not expected to impact trading in the Common Shares, which will continue to trade on Nasdaq under the

symbol “GURE.”

previously announced, on November 5, 2024, the Staff notified the Company that the bid price for the Common Shares had closed below $1.00

per share for 30 consecutive business days and, as a result, the Company no longer satisfied Nasdaq Listing Rule 5450(a)(1), the minimum

bid price requirement applicable to The Nasdaq Global Select Market issuers.

Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company

was afforded an initial 180-calendar day grace period, through May 5, 2025, to regain compliance with the minimum bid price requirement.

listed on The Nasdaq Global Select Market are not eligible for a second 180-day grace period under the Nasdaq Listing Rules.

based upon the Company’s compliance with the various criteria required under Nasdaq Listing Rule 5810(c)(3)(A)(ii) to obtain a second

180-day grace period applicable to issuers listed on The Nasdaq Capital Market, the Company applied to transfer the listing of its Common

Shares to The Nasdaq Capital Market.

As noted above, the Staff approved the Company’s transfer application on May 6, 2025.

Company intends to closely monitor the closing bid price for its Common Shares and consider all available options to timely remedy the

bid price deficiency.

If at any time during the Second Compliance Period, the closing bid price of the Common Shares is at least $1.00

per share for a minimum of 10 consecutive business days, the Staff will provide the Company with written confirmation of compliance and

the matter will be closed, unless the Staff exercises its discretion to extend this ten-day period pursuant to Nasdaq Listing Rule 5810(c)(3)(H).

Company can give no assurance that it will regain or demonstrate compliance during the Second Compliance Period.

If the Company is not

able to demonstrate compliance with the minimum bid price requirement by November 3, 2025, or the Company does not comply with the terms

of the extension, the Staff will provide written notification to the Company that the Common Shares will be delisted.

At that time, the

Company may appeal the Staff’s determination to the Nasdaq Hearings Panel (the “Panel”).

The Company’s appeal

request would stay any delisting action by the Staff at least pending a hearing before the Panel and the expiration of any extension that

may be granted by the Panel to the Company following the hearing.

Company has provided written notice to Nasdaq of its intention to cure the deficiency during the Second Compliance Period by effecting

a reverse stock split, if necessary.

cannot assure you that we will be able to regain compliance with Nasdaq listing standards.

Our failure to continue to meet these requirements

would result in our common stock being delisted from Nasdaq.

We and holders of our securities could be materially adversely impacted if

our securities are delisted from Nasdaq.

In particular:

we may be unable to raise equity capital on acceptable terms or at all;

we may lose the confidence of our customers, which would jeopardize our ability to continue our business as currently conducted;

the price of our common stock will likely decrease as a result of the loss of market efficiencies associated with Nasdaq and the loss of federal preemption of state securities laws;

holders may be unable to sell or purchase our securities when they wish to do so;

we may become subject to stockholder litigation;

we may lose the interest of institutional investors in our common stock;

we may lose media and analyst coverage;

our common stock could be considered a “penny stock,” which would likely limit the level of trading activity in the secondary market for our common stock;

we would likely lose any active trading market for our common stock, as it may only be traded on one of the over-the-counter markets, if at all.

Unregistered Shares of Equity Securities and Use of Proceeds

Investing in our common stock involves a high degree of risk.

you invest you should carefully review our Management’s Discussion and Analysis of Financial Condition and Results of Operations

set forth in Item 2 of Part I of this Quarterly Report on Form 10-Q, our consolidated financial statements and related notes included

in Item 1 of Part I of this Quarterly Report on Form 10-Q and our consolidated financial statements and related notes, as well as our

Management’s Discussion and Analysis of Financial Condition and Results of Operations and the other information in our Annual Report

on Form 10-K for the fiscal year ended December 31, 2024.

Readers should carefully review risks described in other documents we file from

time to time with the Securities and Exchange Commission.

We are currently not in compliance with the Nasdaq continued

listing requirements.

If we are unable to regain compliance with Nasdaq’s listing requirements, our securities could be delisted,

which could affect our common stock’s market price and liquidity and reduce our ability to raise capital.

On May 6, 2025, the Company was notified by the Listing Qualifications

Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Staff granted the Company’s request

to transfer the listing of its common stock, par value $0.0005 per share (the “Common Shares”), from The Nasdaq Global Select

Market tier to The Nasdaq Capital Market tier, and that the Staff granted the Company’s request for a second 180-calendar day period,

or until November 3, 2025 (the “Second Compliance Period”), to regain compliance with the $1.00 bid price requirement, as

set forth in Nasdaq Listing Rule 5550(a)(2).

To regain compliance with such minimum price requirement, the Company must evidence a closing

bid price of at least $1.00 per share for a minimum of 10 consecutive business days.

The transfer of the listing of the Common Shares

from The Nasdaq Global Select Market to The Nasdaq Capital Market took effect with the open of business on May 8, 2025.

The transfer is

not expected to impact trading in the Common Shares, which will continue to trade on Nasdaq under the symbol “GURE.”

As previously announced, on November 5, 2024, the Staff notified the

Company that the bid price for the Common Shares had closed below $1.00 per share for 30 consecutive business days and, as a result, the

Company no longer satisfied Nasdaq Listing Rule 5450(a)(1), the minimum bid price requirement applicable to The Nasdaq Global Select Market

Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was afforded an initial 180-calendar day grace period, through May

5, 2025, to regain compliance with the minimum bid price requirement.

Issuers listed on The Nasdaq Global Select Market are not eligible

for a second 180-day grace period under the Nasdaq Listing Rules.

However, based upon the Company’s compliance with the various

criteria required under Nasdaq Listing Rule 5810(c)(3)(A)(ii) to obtain a second 180-day grace period applicable to issuers listed on

The Nasdaq Capital Market, the Company applied to transfer the listing of its Common Shares to The Nasdaq Capital Market.

As noted above,

the Staff approved the Company’s transfer application on May 6, 2025.

The Company intends to closely monitor the closing bid price for its

Common Shares and consider all available options to timely remedy the bid price deficiency.

If at any time during the Second Compliance

Period, the closing bid price of the Common Shares is at least $1.00 per share for a minimum of 10 consecutive business days, the Staff

will provide the Company with written confirmation of compliance and the matter will be closed, unless the Staff exercises its discretion

to extend this ten-day period pursuant to Nasdaq Listing Rule 5810(c)(3)(H).

The Company can give no assurance that it will regain or demonstrate

compliance during the Second Compliance Period.

If the Company is not able to demonstrate compliance with the minimum bid price requirement

by November 3, 2025, or the Company does not comply with the terms of the extension, the Staff will provide written notification to the

Company that the Common Shares will be delisted.

At that time, the Company may appeal the Staff’s determination to the Nasdaq Hearings

Panel (the “Panel”).

The Company’s appeal request would stay any delisting action by the Staff at least pending a hearing

before the Panel and the expiration of any extension that may be granted by the Panel to the Company following the hearing.

The Company has provided written notice to Nasdaq of its intention

to cure the deficiency during the Second Compliance Period by effecting a reverse stock split, if necessary.

Unregistered Sale of Equity Securities and Use of Proceeds

Defaults Upon Senior Securities

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1A. Risk Factors